BioSpace News Archive

Press Releases

Disc Medicine Announces Positive Pre-NDA Meeting and Confirms Plans to Submit NDA for Bitopertin in Erythropoietic Protoporphyria (EPP) in October 2025

July 22, 2025
·
6 min read
Press Releases

ArriVent’s Topline Pivotal Phase 3 FURVENT Data for Firmonertinib in First-Line NSCLC EGFR Exon20 Insertion Mutations is Projected to be Early 2026

July 22, 2025
·
5 min read
Press Releases

NKGen Receives FDA Expanded Access Protocol Authorization for Landmark Treatment of Several Neurodegenerative Diseases

July 22, 2025
·
5 min read
Press Releases

Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025

July 22, 2025
·
1 min read
Press Releases

ProMIS Neurosciences Granted Fast Track Designation by U.S. FDA for PMN310 in the Treatment of Alzheimer’s Disease

July 22, 2025
·
7 min read
Press Releases

FluoGuide Enters Collaboration with Global MedTech Company Olympus

July 22, 2025
·
3 min read
Press Releases

Protagonist Announces Submission of NDA for First Icotrokinra U.S. FDA Approval Aiming to Revolutionize Treatment Paradigm for Adults and Adolescents with Plaque Psoriasis

July 22, 2025
·
18 min read
Press Releases

Revalesio Announces Publication of RESCUE Phase 2 Trial Results Evaluating RNS60 as an Adjunctive Therapy for Acute Ischemic Stroke in the Journal Stroke

July 22, 2025
·
3 min read
Press Releases

Bruker Announces Second Quarter 2025 Preliminary Results, Plans to Hold Q2 Earnings Conference Call on August 4, 2025

July 22, 2025
·
8 min read
Press Releases

Scholar Rock to Host Conference Call to Discuss Second Quarter 2025 Financial Results and Provide Business Update on August 6, 2025

July 22, 2025
·
2 min read